Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jul 14;53(1):1-5.
doi: 10.1016/j.immuni.2020.06.012. Epub 2020 Jun 23.

The COVID-19 Serology Studies Workshop: Recommendations and Challenges

Andrea M Lerner  1 , Robert W Eisinger  2 , Douglas R Lowy  3 , Lyle R Petersen  4 , Rosemary Humes  5 , Matthew Hepburn  6 , M Cristina Cassetti  7
Affiliations

The COVID-19 Serology Studies Workshop: Recommendations and Challenges

Andrea M Lerner et al. Immunity. .

Abstract

The development, validation, and appropriate application of serological assays to detect antibodies to SARS-CoV-2 are essential to determining seroprevalence of this virus in the United States and globally and in guiding government leadership and the private sector on back-to-work policies. An interagency working group of the US Department of Health and Human Services convened a virtual workshop to identify knowledge gaps and key outstanding scientific issues and to develop strategies to fill them. Key outcomes of the workshop included recommendations for (1) advancing serology assays as a tool to better understand SARS-CoV-2 infection and (2) conducting crucial serology field studies to advance an understanding of immunity to SARS-CoV-2, leading to protection and duration of protection, including the correlation between serological test results and risk of reinfection.

PubMed Disclaimer

References

    1. Amanat F., Stadlbauer D., Strohmeier S., Nguyen T.H.O., Chromikova V., McMahon M., Jiang K., Arunkumar G.A., Jurczyszak D., Polanco J. A serological assay to detect SARS-CoV-2 seroconversion in humans. Nat. Med. 2020 doi: 10.1038/s41591-020-0913-5. - DOI - PMC - PubMed
    1. Bryan A., Pepper G., Wener M.H., Fink S.L., Morishima C., Chaudhary A., Jerome K.R., Mathias P.C., Greninger A.L. Performance Characteristics of the Abbott Architect SARS-CoV-2 IgG Assay and Seroprevalence in Boise, Idaho. J. Clin. Microbiol. 2020 doi: 10.1128/JCM.00941-20. JCM.00941-20. - DOI - PMC - PubMed
    1. Centers for Disease Control and Prevention Coronavirus Disease 2019 (COVID-19): CDC Seroprevalence Survey Types. 2020. https://www.cdc.gov/coronavirus/2019-ncov/covid-data/seroprevalence-type...
    1. Georgia Department of Public Health Georgia Department of Public Health Partners with CDC on COVID-19 Antibody Testing Survey. 2020. https://dph.georgia.gov/press-releases/2020-04-27/georgia-department-pub...
    1. Huang A.T., Garcia-Carreras B., Hitchings M.D.T., Yang B., Katzelnick L., Rattigan S.M., Borgert B., Moreno C., Solomon B.D., Rodriguez-Barraquer I. A systematic review of antibody mediated immunity to coronaviruses: antibody kinetics, correlates of protection, and association of antibody responses with severity of disease. medRxiv. 2020 doi: 10.1101/2020.04.14.20065771. - DOI - PMC - PubMed

Substances